Skip to content
Explore our 2023 annual report to learn about the ground-breaking innovations in cancer research and care happening here at Columbia.
Our researchers are helping to turn the discoveries we make into tomorrow's advanced treatments for our patients.
We work with our communities and patients to remove access barriers to cancer prevention, screening, treatment and survivorship services.
Learn more about the Irving Cancer Drug Discovery Program (ICDDP) at the Herbert Irving Comprehensive Cancer Center.
We're dedicated to developing the next generation of researchers and physicians through cross-disciplinary training and fellowship programs
Two FDA approved drugs show promise in muscle-invasive bladder cancer in mice by transforming tumors into a more benign subtype.
Carmela Brunelli has remained in remission after completing a trial that offers a promising, entirely new bladder-saving treatment option for patients.